Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,237.12
(
0.39%
)
US TECH 100
26,964.80
(
0.96%
)
Dow Jones
49,583.32
(
-0.14%
)
Brent Oil
107.72
(
-2.38%
)
Bitcoin
78,493.16
(
2.83%
)
News Focus
News Focus
Post# of 257481
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122925
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: semi_infinite post# 227448

Friday, 12/06/2019 3:52:47 PM

Friday, December 06, 2019 3:52:47 PM

Post# of 257481
Maybe a small part, but that's all. The AMRN connection you're referring to is that GILD added Vascepa to one of a dozen or so trial arms in a phase-2 NASH trial in progress.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today